HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of anterior glottic restenosis in a canine model with topical mitomycin-C.

Abstract
To develop a model for recurrent anterior glottic stenosis and to test the efficacy of topical mitomycin-C in preventing restenosis, we induced anterior glottic stenosis with a CO2 laser in 5 dogs. In 3 dogs, recurrence was established after surgical lysis. Subsequently, the 3 dogs received a single topical 3-minute treatment with a 1% solution of mitomycin-C after a second surgical lysis. In a parallel experiment, the other 2 dogs received a single topical 3-minute treatment with a 1% solution of mitomycin-C after the initial surgical lysis. An anterior glottic web was induced in all 5 dogs with the CO2 laser. The 3 dogs experienced restenosis at the anterior glottis after surgical lysis alone. Mitomycin-C prevented anterior glottic restenosis in 2 of the 3 dogs treated twice and in both of the dogs treated once (p = .02). We conclude that a recurrent stenosis of the anterior glottis may be induced reproducibly in the canine model with the CO2 laser. Application of topical mitomycin-C after lysis of an anterior glottic stenosis produces a statistically significant reduction in the rate of restenosis as compared to surgical lysis alone.
AuthorsJ E Spector, J A Werkhaven, N C Spector, S Huang, D Sanders, L Reinisch
JournalThe Annals of otology, rhinology, and laryngology (Ann Otol Rhinol Laryngol) Vol. 110 Issue 11 Pg. 1007-10 (Nov 2001) ISSN: 0003-4894 [Print] United States
PMID11713909 (Publication Type: Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Mitomycin
Topics
  • Administration, Topical
  • Animals
  • Antibiotics, Antineoplastic (therapeutic use)
  • Disease Models, Animal
  • Dogs
  • Glottis
  • Laryngostenosis (prevention & control, surgery)
  • Mitomycin (therapeutic use)
  • Postoperative Complications (prevention & control)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: